Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Non-Fasting Conditions

Inclusion Criteria: * Healthy, non-smoking, male and female subjects at least 18 years of age. * BMI (body mass index) of 30 or less. * Females in this study must be physically unable to become pregnant (postmenopausal for at least 6 months or surgically sterile). * Successful completion of a physical examination within 28 days of initiation of the study. * Negative serum pregnancy test (females). Exclusion Criteria: * Subjects with a significant recent history of chronic alcohol consumption (past 2 years), drug addiction, or serious gastrointestinal, renal, hepatic, or cardiovascular disease, tuberculosis, epilepsy, asthma (past 5 years), diabetes, psychosis, or glaucoma will not be eligible for this study. * Subjects whose clinical laboratory test values are outside the reference range and are deemed clinically significant by the Principle Investigator. * Subjects who have a history of allergic responses to the classes of drugs being tested will be excluded from the study. * Subjects who use tobacco in any form will not be eligible to participate in the study. 3 months abstinence is required. * Subjects found to have urine concentrations of any of the tested drugs of abuse will not be allowed to participate. * Subjects should not have donated blood and/or plasma for at least 30 days prior to the first dosing of the study. * Subjects who have taken any investigational drug within 30 days prior to the first dosing of the study will not be allowed to participate. * Female subjects who are pregnant or who are able (women with child bearing potential) to become pregnant during the study will not be allowed to participate. * All female subjects will be screened for pregnancy at check-in each study period. Subjects with positive or inconclusive results will be withdrawn from the study. * Subjects who do not tolerate venipuncture will not be allowed to participate.